Trevena
Latest round
- Series C
Last raised
- May 2013
Total raised
- $125M
Investors
- 6
About Trevena
Trevena, Inc.Founded in 2007 in the United States, Trevena, Inc. specializes in biopharmaceuticals, particularly in developing medications for CNS disorders.25 million shares at USD 7 each.25 million shares.Trevena, Inc. primarily focuses on developing innovative biopharmaceutical products aimed at treating central nervous system (CNS) disorders. The company's core offering is OLINVYK® (oliceridine) injection, an FDA-approved medication designed for managing acute pain, especially in hospital settings. Trevena's pipeline includes investigational candidates such as TRV045 for diabetic neuropathic pain and epilepsy, TRV250 for acute migraine, and TRV734 for opioid use disorder, all developed from Nobel Prize-winning research.Trevena, Inc.125 bn in the most recent year, 2023, primarily through the sale of OLINVYK® to hospitals and healthcare providers. The company uses a direct sales model, leveraging partnerships with distributors to enhance market penetration.Trevena is looking to expand its product offerings, with plans to launch new investigational drugs targeting various CNS disorders. The company aims to penetrate new markets, particularly expanding its reach within the United States and exploring opportunities in international markets.
Who invested in Trevena
6 investors across 7 rounds
See all investors in Trevena
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
May 9, 2013
Amount
$60M
Investors
Series B
Dec 15, 2011
Amount
$3.2M
Investors
Series B
Jul 1, 2011
Amount
$2.4M
Investors
Series B
Jul 14, 2010
Amount
$35M
Investors
Series A
Jun 30, 2009
Amount
$11M
Investors
Series A
Sep 30, 2008
Amount
$8M
Investors
Series A
Jan 31, 2008
Amount
$5M
Investors
Questions about Trevena
Who invested in Trevena?
Trevena has 6 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Trevena raised?
Trevena has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Trevena last raise money?
Trevena's most recent round on record is a Series C, in May 2013.
What does Trevena do?
Trevena is a pharmaceuticals company.
Where is Trevena headquartered?
Trevena is headquartered in US.
Which VCs invest in companies like Trevena?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Trevena's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Trevena? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.